Searching map area
Obinutuzumab plus Bendamustine Followed by Obinutuzumab Maintenance Prolongs Overall Survival Compared with Bendamustine Alone in Patients with Rituximab-Refractory Indolent Non-Hodgkin Lymphoma: Updated Results of the GADOLIN Study
? TBD
scholarly article
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Reading
Full Textashpublications.org
Elsewhere
Originalashpublications.org
Instance of
Scholarly article
Author
Pieternella J Lugtenburg
References
Wikidata